Mark Strobeck - 01 Apr 2025 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)

Signature
/s/ Megan Timmins, Attorney-in-Fact for Mark Strobeck
Issuer symbol
RMTI
Transactions as of
01 Apr 2025
Net transactions value
-$7,480
Form type
4
Filing time
02 Apr 2025, 18:06:41 UTC
Previous filing
18 Mar 2025
Next filing
21 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMTI Common Stock Sale $7,480 -6,926 -5.3% $1.08 124,678 01 Apr 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024 in multiple trades at prices ranging from $1.065 to $1.12. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.